HIGHLIGHTS
- who: . and collaborators from the Universitu00e9 Claude Bernard Lyon, France University Hospital Wu00fcrzburg, Germany have published the paper: Effect of the 3q26-coding oncogene SEC62 as a potential prognostic marker in patients with ovarian neoplasia, in the Journal: (JOURNAL) of 13/07/2022
- what: In light of the findings of Hagerstrand et_al who identified SEC62 as a potential tumor-driver-gene for the development of ovarian cancer and the prognostic impact of SEC62 in other tumor entities (Hagerstrand et_al, 2013), the aim of this study was to assess the role of SEC62 as a possible . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.